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See Article, pages 481–488Understanding the mechanisms that govern liver regeneration is
a matter of paramount importance in the context of human liver
disease. In the clinical setting this remarkable reaction takes
place in a variety of situations including partial liver resection,
organ transplantation and toxic injury, and when it fails the
consequences can be fatal [1]. Liver regeneration is a highly com-
plex response, involving the whole organ with its different con-
stituent cell types, and an intricate network of extracellular and
intracellular signals and mediators [2–4]. Most of our current
knowledge on the mechanisms of liver regeneration has been
gathered in the experimental model of partial hepatectomy
(PH) in rodents [5]. Removal of 2/3 of the liver mass quickly trig-
gers an orderly sequence of events in the remaining parenchyma,
leading to hepatocyte proliferation and the restoration of normal
liver weight 5–7 days after PH [5,6]. In this highly reproducible
model the kinetics of the underlying proliferative events is well
synchronized, allowing a ﬁne molecular analysis of organ regen-
eration in vivo that has attracted the attention not only of
hepatologists but of researchers from other ﬁelds of biology as
well.
The identiﬁcation of the signals that trigger and terminate
liver regeneration is an area of active investigation. Observations
performed in the PH model over the past decades have put for-
ward a number of intertwined signals and agents that when deﬁ-
cient or functionally blocked result in a defective regenerative
response. These include a diversity of molecules such as cyto-
kines like tumour necrosis factor alpha and components of the
innate immune system, growth factors like hepatocyte growth
factor and different members of the epidermal growth factor
(EGF) family, transforming growth factor beta, as well as hor-
mones (insulin), neurotransmitters (norepinephrine) and metab-
olites (bile acids) [2–4,6]. In spite of the wealth of information on
the role of these factors in liver cell proliferation, knowledge on
the mechanisms leading to their initial activation at the onset
of liver regeneration is limited. Nonetheless, there are evidencesJournal of Hepatology 20
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ing increased portal vein pressure and liver tissue perfusion, as
critical events in the initiation of the regenerative response in
the remaining parenchyma [4,7].
The circulating concentrations of most of the factors that par-
ticipate in liver regeneration increase shortly after PH. Although
many of these mediators are produced and accumulate within
the regenerating liver, there are also evidences indicating the
implication of other organs as sources of factors necessary for
hepatic regeneration to proceed normally [6]. One such example
is EGF, which is constitutively produced by the Brunner’s glands
of the duodenum and reaches the liver though the portal circula-
tion at threefold higher concentrations per unit tissue after 2/3
PH [6]. Another endocrine factor involved in liver regeneration
is arginine vasopressin [AVP]. AVP is a peptide produced by endo-
crine neurons in the supraoptic and paraventricular nuclei of the
hypothalamus. Early reports pointed to its involvement in liver
regeneration by demonstrating an impaired liver regeneration
after PH in the AVP-deﬁcient Brattleboro homozygote rats [8],
and by the fact that AVP could induce DNA synthesis in cultured
rat hepatocytes [9]. More recently the group of Tordjmann and
co-workers demonstrated that plasma concentrations of AVP rise
sharply after PH, peaking at 1 h after surgery, and provided phar-
macological evidence showing that antagonism with AVP action
signiﬁcantly reduced liver regeneration in normal hepatecto-
mized rats [10]. As occurs for other mediators of liver regenera-
tion, the signals that stimulated AVP-secreting neurons in the
hypothalamic nuclei upon PH were not known. Their identiﬁca-
tion was the aim of the current report by Doignon et al. in this
issue of the Journal [11].
The search for signals able to stimulate AVP release during PH
was guided by previous observations demonstrating the secre-
tion of AVP in independent physio-pathological situations that
to a certain extent also occur after liver resection. Two possible
pathways were considered, one involved the recognition that
portal hypertension was known to induce AVP release [12,13],
and the other was based on the observation that AVP secretion
is stimulated during chronic cholestasis after bile duct ligation
(BDL) in rats [14]. In view of this, experiments were carefully
designed to test the inﬂuence of portal hypertension and circulat-
ing bile acids on AVP production during liver regeneration after11 vol. 54 j 403–405
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PH. Regarding the role of hemodynamic changes, the authors ﬁrst
showed that in the absence of liver resection an increase in portal
vein pressure to levels equivalent to those observed after PH
resulted in the activation of AVP-producing hypothalamic neu-
rons, and in AVP secretion to the circulation. In order to directly
assess the contribution of portal hyperpressure to AVP release
after PH, liver resection was performed in rats with porto-caval
anastomosis (PCA), a surgical modiﬁcation that prevents extrahe-
patic portal vein pressure increase after hepatectomy. The ﬁnding
that AVP-producing hypothalamic nuclei were still activated by
PH under these conditions led the authors to suggest that intra-
hepatic hyperpressure, which is preserved in PCA rats, could be
sufﬁcient to promote AVP release. Nevertheless, the implication
of a neural pathway in the rapid secretion of AVP after PH was
substantiated by showing that release of this peptide was
impaired in rats with chemical (capsaicin) or surgical (spinal cord
lesions) afferent denervation. These ﬁndings add on the previ-
ously recognized role of the peripheral nervous system in liver
regeneration after PH [6], and deﬁne a regulatory control loop
in which signals triggered by baroreceptors in the liver travel to
the hypothalamus eliciting AVP secretion. As discussed by the
authors, given the ability of AVP to reduce portal blood ﬂow,
the released AVP could not only contribute to liver regeneration,
but also to lower portal vein pressure.
The second pathway potentially responsible for AVP produc-
tion during liver regeneration considered in this study was
related to the elevation of plasma bile acids observed after PH.
Increased circulating levels of bile acids during liver regeneration
had been previously reported [15,16]. This was conﬁrmed now by
Doignon et al., who also demonstrated the accumulation of these
molecules in the rat hypothalamus after PH and BDL [11]. Bile
acids are emerging as potent regulatory molecules, with biologi-
cal roles that exceed their traditional function in lipid digestion
[17]. These molecules have been directly involved in the regula-
tion of liver regeneration through their interaction with the
nuclear receptor FXR [15]. However, bile acids can bind and acti-
vate another receptor known as GPBAR1 or TGR5, a G protein
coupled receptor present at the plasma membrane that conveys
important regulatory intracellular signals in a variety of cells
[17,18]. Expression of TGR5 was also detected in the rat and
mouse hypothalamus by Doignon et al. [11], and the availability
of TGR5 knockout mice (TGR5-KO) allowed testing the implica-
tion of this receptor in AVP release. Intriguingly, while AVP secre-
tion upon BDL was attenuated in TGR5-KO mice compared to
wild type animals, plasma AVP levels were similar in both geno-
types after PH [11]. The authors speculate that additional stimuli,
independent of TGR5, may be involved in AVP release after PH,
and invoke the plasticity of the hepatic regenerative response
characterized by the existence of multiple compensatory path-
ways [6]. However, we cannot overlook the fact that TGR5 is also
expressed in two liver cell populations, Kupffer cells and sinusoi-
dal endothelial cells, in which bile acids regulate cytokine pro-
duction and NO synthesis [18], important players in the
regulation of liver regeneration and intrahepatic microcircula-
tion. This situation, together with the fact that TGR5-KO mice
have a 20% decrease in bile acid pool size [19], may complicate
the interpretation of data regarding TGR5-mediated regulation of
AVP in these animals. In view of this, it would be interesting to
test AVP secretion during liver regeneration in tissue-speciﬁc
TGR5-KO mice, ideally with targeted deletion of this receptor in
AVP-producing cells.404 Journal of Hepatology 201Finally, the authors also provide valuable observations on AVP
levels in human liver donors for transplantation after right lobe
hepatectomy, and in recipients after graft reperfusion [11]. Consis-
tent with the experimental ﬁndings they show for the ﬁrst time
that circulating AVP levels rise shortly after PH in human donors.
This responsewas accompanied by an increase in portal vein pres-
sure and in plasma bile acid concentrations in hepatectomized
patients. Interestingly, AVP levels were notmodiﬁed in the plasma
of liver graft recipients after reperfusion. Even though plasma bile
acid concentrations were not measured in these patients, the fact
that the grafted liver lacks innervation together with the normal
secretion of AVP in TGR5-KOmice after PH, may suggest a prepon-
derance of the neural pathway over the bile acid-mediated endo-
crine route for AVP regulation in liver regeneration. Furthermore,
such predominant role of the nervous route may be more promi-
nent in humans than in rodents, given the more profuse hepatic
innervation found in primates [20]. Therefore the precise elucida-
tion of the nerve routes involved deserves further studies.
In summary, thiswork provides novel and relevant information
on the regulation of AVP production after PH, both experimental
and clinical. Moreover, it nicely illustrates and contributes to
deﬁne the complex interactions between the liver and other tis-
sues during the extraordinary regenerative response of the liver.Conﬂict of interest
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